Skip to main content


Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
Quick Connect

Pharma API Manufacturing Capabilities

Pharma API Manufacturing Capabilities

Pharma API Manufacturing Capabilities
Pharma API Manufacturing Capabilities

Dr. Reddy’s Manufacturing Capabilities:

With an industry-leading portfolio of generic APIs and a proven track record in drug product development, we are among the earliest pharma API manufacturer with a vast portfolio of APIs and the preferred API partner of choice for pharma companies in more than 80+ countries. Our API manufacturing facilities are complemented by formulation facilities supplying various dosage forms.

Our business thrives on the deep technical strengths established over the last 30+ years in developing and manufacturing complex APIs such as steroids, peptides, complex long-chain molecules, and highly potent APIs. Dr. Reddy's successfully supplied APIs and finished dosage forms to various customers worldwide, and many customers have filed their dossiers and commercialized them in their respective countries.

Our API manufacturing facilities are operated in accordance with cGMP ICH Q7 guidance and are regularly inspected/audited by international regulatory authorities and numerous customers. We manufacture our APIs at our cGMP API manufacturing facility, which was successfully inspected by international regulatory authorities such as the USFDA, EMEA, ANVISA, PMDA, H`ealth Canada, etc.

We are multi-sourced on our KSMs for a sustainable supply; we have reliable KSM suppliers to ensure timely deliveries and adhere to stringent specifications. With additional capacity enhancement and API manufacturing facilities we are well-positioned to meet the global demands of essential APIs and future supply requirements.

Overview of Dr. Reddy’s API Manufacturing Facilities

Manufacturing Location

Dr. Reddy’s API  Manufacturing Locations

We are here to help, if you have any country specific requirements.

Manufacturing Capabilities

Dr. Reddy’s API  Manufacturing Capabilities
  • 170+ APIs
  • 4,100+ KL of reactor volumes.
  • 1250+ Reactors including ~100+ reactors with containment across 4 sites (HPAI /Oncology/ steroids/prostaglandins).
  • 5,000+ MT of Intermediates manufactured.
  • 90% of our API pipeline is forward integrated to generic formulations.
  • 100+ Commercial Molecules
  • 50+ Pipeline molecules (Filed + under development).
  • 2,100+ MT of APIs manufactured.
  • Deep expertise in handing complex peptide molecules.
  • Can handle molecules of OEL up to 0.1 µg/m3 by protecting environment, people & product.

Related Pages

Portfolio of 150+ APIs

R & D

Global manufacturing network of 8 sites

Customer Service

Strong R&D capabilities

Regulatory

X
Checked out our

API Linkedin
page yet?

Follow this page to explore how our offerings can accelerate your formulation success

Click here to visit